Uncategorized
VIDEO: Khanani delves into data from OPTIC trial
Arshad M. Khanani, MD, discusses results from the phase 1 OPTIC trial of ADVM-022 intravitreal injection gene therapy (Adverum Biotechnologies) for the treatment of wet age-related macular degeneration presented at the virtual Association for Research in Vision and Ophthalmology meeting.